We are live on ! Find out more
AEON icon

AEON Biopharma
AEON

18 hedge funds and large institutions have $586K invested in AEON Biopharma in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

13% more funds holding

Funds holding: 16 → 18 (+2)

3.25% less ownership

Funds ownership: 14.5% → 11.24% (-3.3%)

34% less capital invested

Capital invested by funds: $885K → $586K (-$299K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DIG
Dauntless Investment Group
New Hampshire
+$57.4K
2
HF
HRT Financial
New York
+$26K
3
UBS Group
UBS Group
Switzerland
+$16.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.9K
5
Citigroup
Citigroup
New York
+$156

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$261K
2
BlackRock
BlackRock
New York
-$468
Name Holding Trade Value Shares
Change 		Change in
Stake
DIG
1
Dauntless Investment Group
New Hampshire
$475K +$57.4K +100,000 +10%
HF
2
HRT Financial
New York
$34K +$26K +45,258 New
BOCH
3
Blue Owl Capital Holdings
New York
$32.2K – – –
UBS Group
4
UBS Group
Switzerland
$24K +$16.4K +28,643 +969%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$15.7K +$11.9K +20,695 New
BlackRock
6
BlackRock
New York
$2.17K -$468 -816 -22%
Bank of America
7
Bank of America
North Carolina
$1.81K +$38 +66 +3%
Citigroup
8
Citigroup
New York
$207 +$156 +272 New
DCM
9
Dupont Capital Management
Delaware
$129 – – –
Morgan Stanley
10
Morgan Stanley
New York
$114 – – –
SS
11
SBI Securities
Japan
$81 – – –
SPIA
12
Steward Partners Investment Advisory
New York
$76 – – –
Wells Fargo
13
Wells Fargo
California
$68 – – –
WWM
14
Wolff Wiese Magana
California
$51 – – –
MCM
15
MAI Capital Management
Ohio
$45 – – –
CIBC Private Wealth Group
16
CIBC Private Wealth Group
Georgia
$25 – – –
GIA
17
GHP Investment Advisors
Colorado
$19 +$5 +9 +60%
DB
18
Danske Bank
Denmark
$1 – – –
SM
19
Sabby Management
Florida
– -$261K -449,687 Closed

AEON Hedge Fund Activity: Q2 2025 in Review

18 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma (AEON) for Q2 2025, worth a combined $586K — down 34% from $885K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AEON positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Dauntless Investment Group, adding an estimated $57.4K. The largest seller was Sabby Management, exiting entirely with an estimated $261K sold.

  • 18 institutional investors held AEON Biopharma (AEON) as of Q2 2025, up from 16 in Q1 2025.
  • Funds reported $586K of AEON Biopharma stock for Q2 2025, down 34% quarter-over-quarter.
  • 3 funds opened new AEON Biopharma positions in Q2 2025 and 1 closed out, a net change of +2 holders.
  • The largest AEON Biopharma buyer in Q2 2025 was Dauntless Investment Group, an estimated $57.4K added.
  • The largest AEON Biopharma seller in Q2 2025 was Sabby Management, an estimated $261K sold.

Based on aggregated 13F filings for Q2 2025.